Zdrowie i gospodarka · 05/05/2022
FDA Releases Draft Guidance on Clinical Pharmacology Considerations for Human Radiolabeled Mass Balance Studies
The Food and Drug Administration (FDA) has released a draft guidance for industry on clinical pharmacology considerations for human radiolabeled mass balance studies, outlining the agency's recommendations for conducting these studies.
Source: Federal Register — Food and Drug AdministrationOpen original release →